0113 2727560

Contact Us

Contact CPWY

Twitter Latest Tweets

Latest PSNC News

May 2019 Price Concessions – 1st update

Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions: Drug Pack size Price Concession Amiloride 5mg tablets 28 £9.49 Betahistine 8mg tablets 84 £2.61 Candesartan 8mg tablets 28 £2.50 Candesartan 32mg tablets 28 £2.49 Carvedilol 3.125mg tablets 28 £1.16 Carvedilol 12.5mg tablets 28 £2.20 Carvedilol 25mg tablets...

3 hours ago

Diamorphine 5mg injections, Microgynon 30 and Ovranette tablets – Supply update

Supply Update Diamorphine 5mg injections Accord and Wockhardt have notified the Department of Health and Social Care (DHSC) and NHS England (NHSE) that they are experiencing issues with the manufacture and availability of Diamorphine 5mg injections. There is an anticipated out of stock period between 27th May 2019 and w/c 5th August 2019. It is...

3 hours ago

Supporting the development of primary care networks: NHS England webinars

In order to support the ongoing development of Primary Care Networks (PCNs), NHS England will be hosting two webinars on the role of pharmacy within PCNs as part of a webinar series. The webinars are aimed at those working within primary care and the wider NHS and will include examples of work already in progress...

10 hours ago

Healthy Hearts Programme in West Yorkshire – April 2019

 

Pharmacies in West Yorkshire may notice changes in patient prescriptions over the coming months, with an increase in the number of those being prescribed antihypertensives along with changes to existing prescriptions for patients being treated for hypertension. 

The changes are a result of the new West Yorkshire and Harrogate Healthy Hearts programme, which aims to help reduce the impact of heart disease and prevent the number of heart-related illnesses, including heart attacks, stroke and diabetes, every year across the region. 

The implementation resource highlights community pharmacy as the place for patients to be referred to for the New Medicines Service (NMS) and Medicines Use Reviews (MURs) so you will notice more patients asking for your help and advice with their hypertension medication. The Treatment Guidance has more detail on the clinical pathway for patients to help you understand the treatment choice for the patient. 

The programme, which is being delivered by the Yorkshire & Humber Academic Health Science Network, aims to reduce the number of people affected by heart disease by 10 per cent by 2021, meaning 1,100 fewer heart incidents by 2021. 

To support this, a website has been created that will be continuously developed into a storehouse of trusted information on CVD and its related conditions for both the public and local health care professionals across the region. 

West Yorkshire and Harrogate Healthy Hearts will be delivered in three phases. Phase one sees it working to help GPs identify patients with high blood pressure who haven’t yet been diagnosed, as well as helping to optimise the treatment of those already diagnosed through improvements to their individual medication, and providing advice and support on the kinds of lifestyle changes needed to stay healthy. 

Phase two of the project will see an emphasis on lipid/cholesterol management and is due to begin in the autumn of 2019. Phase three, set to begin in 2020, will see a concentration on glycaemic control in diabetes. 

Please keep your eye out for any further updates on how you can be involved in this project and if you have any questions or queries then please contact Melissa Burnley by email at melissa@cpwy.org.

 

 

Last Updated: 1st May 2019